ReadCoor

ReadCoor Inc is a next-generation sequencing company based on research results from Harvard University in the United States, providing a brand-new gene localization imaging platform. It has developed the FISSEQ platform, which integrates high-throughput sequencing, morphometric analysis, cell localization, and three-dimensional spatial imaging to understand the transcriptome, offering new diagnostic and therapeutic opportunities for cancer, immuno-oncology, infectious diseases, neurogenic and neuromuscular diseases, brain function, and cognitive disorders.